Skip to main content
logo
Hawesko Holding SE (FRA:HAW)
Germany flag Germany · Delayed Price · Currency is EUR
23.20
+0.30 (1.31%)
Last updated: Jul 31, 2025

Intra-Cellular Therapies Revenue

Hawesko Holding SE had revenue of 135.30M EUR in the quarter ending March 31, 2025, a decrease of -5.17%. This brings the company's revenue in the last twelve months to 632.60M, down -1.34% year-over-year. In the year 2024, Hawesko Holding SE had annual revenue of 639.97M, down -1.79%.

Revenue (ttm)
632.60M
Revenue Growth
-1.34%
P/S Ratio
0.33
Revenue / Employee
530.70K
Employees
1,192
Market Cap
207.52M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024639.97M-11.70M-1.79%
Dec 31, 2023651.67M-20.00M-2.98%
Dec 31, 2022671.66M-8.91M-1.31%
Dec 31, 2021680.57M59.87M9.64%
Dec 31, 2020620.70M64.15M11.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
SAP SE35.89B
Siemens Aktiengesellschaft77.82B
Deutsche Telekom AG120.25B
Allianz SE109.03B
Siemens Energy AG37.44B
Rheinmetall AG10.48B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München61.84B
Deutsche Bank Aktiengesellschaft30.07B
Revenue Rankings

Hawesko Holding SE News

More News